IMMUNE-MEDIATED HEPATIC DISORDER

This adverse event was reported 1952 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED HEPATIC DISORDER:

# Drug Count
0 PEMBROLIZUMAB 1047
1 NIVOLUMAB 603
2 IPILIMUMAB 417
3 CARBOPLATIN 359
4 PACLITAXEL 245
5 PACLITAXEL (AIBUMIN-BOUND) 226
6 DURVALUMAB 150
7 PEMETREXED DISODIUM 129
8 CISPLATIN 105
9 TREMELIMUMAB 97
See all common drugs associated with IMMUNE-MEDIATED HEPATIC DISORDER

IMMUNE-MEDIATED HEPATIC DISORDER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TREMELIMUMAB 97 0.0219
1 ADENINE 1 0.0204
2 ETRANACOGENE DEZAPARVOVEC 1 0.0154
3 NALDEMEDINE 20 0.0120
4 PEMBROLIZUMAB 1047 0.0096
5 IPILIMUMAB 417 0.0095
6 DURVALUMAB 150 0.0070
7 NIVOLUMAB 603 0.0062
8 SENNOSIDES A AND B 10 0.0061
9 MIGLITOL 5 0.0052
See all drugs enriched for association with IMMUNE-MEDIATED HEPATIC DISORDER